Naltrexone and Propranolol Combined With Immunotherapy

Clinical trial NCT05968690 · RECRUITING

Trial details

NCT number: NCT05968690
Sponsor: Sarah Weiss
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Melanoma

Start date: 2023-09-11
Primary completion: 2026-09-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.